NICE, Alzheimer's and the QALY

Clinical Ethics 2 (1):50-54 (2007)
  Copy   BIBTEX

Abstract

The introduction of National Institute for Health and Clinical Excellence (NICE) guidance on Alzheimer's medication in November 2006 will have a significant effect on the treatment of patients, and is opposed by the Royal College of Psychiatrists and many charities dealing with the elderly. The use of the Quality-Adjusted Life Year (QALY) in the guidance formulation is much debated due to questions of ageism. This article seeks to examine the basis of these accusations and whether NICE can be justified using a utilitarian calculation in a principally egalitarian system such as the NHS

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,227

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Qualité de la vie et affectation des ressources.Michael Lockwood - 1987 - Revue de Métaphysique et de Morale 92 (3):307 - 328.
Nice and not so nice.J. Harris - 2005 - Journal of Medical Ethics 31 (12):685-688.
The burden of dementia: A medical and research perspective.Piero Antuono & Jan Beyer - 1999 - Theoretical Medicine and Bioethics 20 (1):3-13.
Lifetime QALY prioritarianism in priority setting.Trygve Ottersen - 2013 - Journal of Medical Ethics 39 (3):175-180.

Analytics

Added to PP
2010-08-24

Downloads
122 (#148,660)

6 months
6 (#529,161)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

J. W. Taylor
Misericordia University

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references